Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
1,200,100
-
Share change
-
+111,588
-
Total reported value
-
$79,018,098
-
Price per share
-
$65.84
-
Number of holders
-
95
-
Value change
-
+$7,608,470
-
Number of buys
-
35
-
Number of sells
-
32
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q4 2023
As of 31 Dec 2023,
INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,200,100 shares.
The largest 10 holders included
Gerber Kawasaki Wealth & Investment Management, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, LPL Financial LLC, UBS Group AG, BANK OF AMERICA CORP /DE/, CreativeOne Wealth, LLC, YHB Investment Advisors, Inc., and Institute for Wealth Management, LLC..
This page lists
96
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.